SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glaxosmithkline Pharmaceuticals informs about press release

03 Mar 2020 Evaluate

Glaxosmithkline Pharmaceuticals has informed that the company has enclosed a press release issued by the Company on 3 March 2020 regarding ‘Sridhar Venkatesh appointed as Managing Director & VP of GSK India effective 1 April 2020’.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2577.15 10.60 (0.41%)
06-Aug-2026 15:11 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1951.90
Dr. Reddys Labs. 1172.60
Cipla 1474.60
Lupin 2392.80
Zydus Lifesciences 1102.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: